Loading…

Contralateral second dose improves antibody responses to a 2-dose mRNA vaccination regimen

FUNDING. M.J. Murdock Charitable Trust, OHSU Foundation, NIH.

Saved in:

Bibliographic Details
Published in:	The Journal of clinical investigation 2024-03, Vol.134 (6)
Main Authors:	Fazli, Sedigheh, Thomas, Archana, Estrada, Abram E, Ross, Hiro A.P, Lee, David Xthona, Kazmierczak, Steven, Slifka, Mark K, Montefiori, David, Messer, William B, Curlin, Marcel E
Format:	Article
Language:	English
Subjects:	B cells Biotechnology industry Health aspects Immune response Immunoglobulin G Messenger RNA Physiological aspects Vaccination
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by
cites
container_end_page
container_issue	6
container_start_page
container_title	The Journal of clinical investigation
container_volume	134
creator	Fazli, Sedigheh Thomas, Archana Estrada, Abram E Ross, Hiro A.P Lee, David Xthona Kazmierczak, Steven Slifka, Mark K Montefiori, David Messer, William B Curlin, Marcel E
description	FUNDING. M.J. Murdock Charitable Trust, OHSU Foundation, NIH.
doi_str_mv	10.1172/JCI176411.
format	article
fullrecord	<record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A790361067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A790361067</galeid><sourcerecordid>A790361067</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1737-fa9fdc7f385c63c4c2b4ba172c038a7e0875b9f1eee0847be50e3d52cb6e3c013</originalsourceid><addsrcrecordid>eNqNz0tLxDAQB_AcFFxXL36CgCcPrUmTNu2xFB8riwvr4-BlSdNJibTJsomLfnvj4-DCHmQgE4bfDPwROqMkpVRkl3fNjIqCU5oeoAkhGU0qwcojdOz9KyGU85xP0EvjbNjIQQaIL_agnO1w5zxgM643bgseSxtM67oPvAG_dtbHUXBY4iz5duPyvsZbqZSxMhhnI-vNCPYEHWo5eDj97VP0dH312Nwm88XNrKnnSU8FE4mWle6U0KzMVcEUV1nLWxkDKMJKKYCUIm8rTQHil4sWcgKsyzPVFsAUoWyKzn_u9nKAlbHaxUBqNF6talERVlBSiKiSPaoH-5XbWdAmjnd8usfH6mA0au_Cxc5CNAHeQy_fvF_NHpb_t4vnv_YTGTGMyw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Contralateral second dose improves antibody responses to a 2-dose mRNA vaccination regimen</title><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Fazli, Sedigheh ; Thomas, Archana ; Estrada, Abram E ; Ross, Hiro A.P ; Lee, David Xthona ; Kazmierczak, Steven ; Slifka, Mark K ; Montefiori, David ; Messer, William B ; Curlin, Marcel E</creator><creatorcontrib>Fazli, Sedigheh ; Thomas, Archana ; Estrada, Abram E ; Ross, Hiro A.P ; Lee, David Xthona ; Kazmierczak, Steven ; Slifka, Mark K ; Montefiori, David ; Messer, William B ; Curlin, Marcel E</creatorcontrib><description>FUNDING. M.J. Murdock Charitable Trust, OHSU Foundation, NIH.</description><identifier>ISSN: 0021-9738</identifier><identifier>DOI: 10.1172/JCI176411.</identifier><language>eng</language><publisher>American Society for Clinical Investigation</publisher><subject>B cells ; Biotechnology industry ; Health aspects ; Immune response ; Immunoglobulin G ; Messenger RNA ; Physiological aspects ; Vaccination</subject><ispartof>The Journal of clinical investigation, 2024-03, Vol.134 (6)</ispartof><rights>COPYRIGHT 2024 American Society for Clinical Investigation</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Fazli, Sedigheh</creatorcontrib><creatorcontrib>Thomas, Archana</creatorcontrib><creatorcontrib>Estrada, Abram E</creatorcontrib><creatorcontrib>Ross, Hiro A.P</creatorcontrib><creatorcontrib>Lee, David Xthona</creatorcontrib><creatorcontrib>Kazmierczak, Steven</creatorcontrib><creatorcontrib>Slifka, Mark K</creatorcontrib><creatorcontrib>Montefiori, David</creatorcontrib><creatorcontrib>Messer, William B</creatorcontrib><creatorcontrib>Curlin, Marcel E</creatorcontrib><title>Contralateral second dose improves antibody responses to a 2-dose mRNA vaccination regimen</title><title>The Journal of clinical investigation</title><description>FUNDING. M.J. Murdock Charitable Trust, OHSU Foundation, NIH.</description><subject>B cells</subject><subject>Biotechnology industry</subject><subject>Health aspects</subject><subject>Immune response</subject><subject>Immunoglobulin G</subject><subject>Messenger RNA</subject><subject>Physiological aspects</subject><subject>Vaccination</subject><issn>0021-9738</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqNz0tLxDAQB_AcFFxXL36CgCcPrUmTNu2xFB8riwvr4-BlSdNJibTJsomLfnvj4-DCHmQgE4bfDPwROqMkpVRkl3fNjIqCU5oeoAkhGU0qwcojdOz9KyGU85xP0EvjbNjIQQaIL_agnO1w5zxgM643bgseSxtM67oPvAG_dtbHUXBY4iz5duPyvsZbqZSxMhhnI-vNCPYEHWo5eDj97VP0dH312Nwm88XNrKnnSU8FE4mWle6U0KzMVcEUV1nLWxkDKMJKKYCUIm8rTQHil4sWcgKsyzPVFsAUoWyKzn_u9nKAlbHaxUBqNF6talERVlBSiKiSPaoH-5XbWdAmjnd8usfH6mA0au_Cxc5CNAHeQy_fvF_NHpb_t4vnv_YTGTGMyw</recordid><startdate>20240315</startdate><enddate>20240315</enddate><creator>Fazli, Sedigheh</creator><creator>Thomas, Archana</creator><creator>Estrada, Abram E</creator><creator>Ross, Hiro A.P</creator><creator>Lee, David Xthona</creator><creator>Kazmierczak, Steven</creator><creator>Slifka, Mark K</creator><creator>Montefiori, David</creator><creator>Messer, William B</creator><creator>Curlin, Marcel E</creator><general>American Society for Clinical Investigation</general><scope>IOV</scope><scope>ISR</scope></search><sort><creationdate>20240315</creationdate><title>Contralateral second dose improves antibody responses to a 2-dose mRNA vaccination regimen</title><author>Fazli, Sedigheh ; Thomas, Archana ; Estrada, Abram E ; Ross, Hiro A.P ; Lee, David Xthona ; Kazmierczak, Steven ; Slifka, Mark K ; Montefiori, David ; Messer, William B ; Curlin, Marcel E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1737-fa9fdc7f385c63c4c2b4ba172c038a7e0875b9f1eee0847be50e3d52cb6e3c013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>B cells</topic><topic>Biotechnology industry</topic><topic>Health aspects</topic><topic>Immune response</topic><topic>Immunoglobulin G</topic><topic>Messenger RNA</topic><topic>Physiological aspects</topic><topic>Vaccination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fazli, Sedigheh</creatorcontrib><creatorcontrib>Thomas, Archana</creatorcontrib><creatorcontrib>Estrada, Abram E</creatorcontrib><creatorcontrib>Ross, Hiro A.P</creatorcontrib><creatorcontrib>Lee, David Xthona</creatorcontrib><creatorcontrib>Kazmierczak, Steven</creatorcontrib><creatorcontrib>Slifka, Mark K</creatorcontrib><creatorcontrib>Montefiori, David</creatorcontrib><creatorcontrib>Messer, William B</creatorcontrib><creatorcontrib>Curlin, Marcel E</creatorcontrib><collection>Gale_Opposing Viewpoints In Context</collection><collection>Gale In Context: Science</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fazli, Sedigheh</au><au>Thomas, Archana</au><au>Estrada, Abram E</au><au>Ross, Hiro A.P</au><au>Lee, David Xthona</au><au>Kazmierczak, Steven</au><au>Slifka, Mark K</au><au>Montefiori, David</au><au>Messer, William B</au><au>Curlin, Marcel E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Contralateral second dose improves antibody responses to a 2-dose mRNA vaccination regimen</atitle><jtitle>The Journal of clinical investigation</jtitle><date>2024-03-15</date><risdate>2024</risdate><volume>134</volume><issue>6</issue><issn>0021-9738</issn><abstract>FUNDING. M.J. Murdock Charitable Trust, OHSU Foundation, NIH.</abstract><pub>American Society for Clinical Investigation</pub><doi>10.1172/JCI176411.</doi></addata></record>
fulltext	fulltext
identifier	ISSN: 0021-9738
ispartof	The Journal of clinical investigation, 2024-03, Vol.134 (6)
issn	0021-9738
language	eng
recordid	cdi_gale_infotracmisc_A790361067
source	PubMed Central; EZB Electronic Journals Library
subjects	B cells Biotechnology industry Health aspects Immune response Immunoglobulin G Messenger RNA Physiological aspects Vaccination
title	Contralateral second dose improves antibody responses to a 2-dose mRNA vaccination regimen
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T12%3A08%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Contralateral%20second%20dose%20improves%20antibody%20responses%20to%20a%202-dose%20mRNA%20vaccination%20regimen&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=Fazli,%20Sedigheh&rft.date=2024-03-15&rft.volume=134&rft.issue=6&rft.issn=0021-9738&rft_id=info:doi/10.1172/JCI176411.&rft_dat=%3Cgale%3EA790361067%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g1737-fa9fdc7f385c63c4c2b4ba172c038a7e0875b9f1eee0847be50e3d52cb6e3c013%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A790361067&rfr_iscdi=true